DA
MRK icon

Dunvegan Associates’s Merck MRK Stock Holding History

Dunvegan Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$67K Hold
1,326
– – 0.08% 78
2015
Q3 		$63K Hold
1,326
– – 0.07% 78
2015
Q2 		$72K Hold
1,326
– – 0.08% 77
2015
Q1 		$73K Hold
1,326
– – 0.06% 93
2014
Q4 		$72K Hold
1,326
– – 0.06% 93
2014
Q3 		$75K Hold
1,326
– – 0.07% 83
2014
Q2 		$73K Hold
1,326
– – 0.06% 91
2014
Q1 		$72K Buy
+1,326
New +$68.7K 0.06% 84

Other funds holding MRK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dunvegan Associates's MRK Position: Q4 2015 in Review

Dunvegan Associates held its Merck (MRK) position steady in Q4 2015 at 1,326 shares worth $67K. The position accounts for 0.08% of the portfolio, ranked #78.

Dunvegan Associates first reported a position in MRK in Q1 2014 and has held it in 8 quarters since. The position peaked at $75K in Q3 2014. 1,755 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

  • Dunvegan Associates held 1,326 shares of Merck worth $67K as of Q4 2015.
  • Dunvegan Associates left its Merck share count unchanged in Q4 2015.
  • Merck made up 0.08% of Dunvegan Associates's portfolio in Q4 2015, its #78 holding.
  • Dunvegan Associates first reported a position in Merck in Q1 2014 and has held it in 8 quarters since.
  • Dunvegan Associates's Merck position peaked at $75K in Q3 2014.
  • 1,755 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.